Projects
- 
                        Evaluation of the effects of Oryzon Genomics proprietary compounds on pediatric patient tumors- Leader
- Jaume Mora Graupera
- Announcement
- Conveni
- Code
- PCP00325
- Starting date
- 2021
- End date
- 2022
- Funded by
- Oryzon Genomics S.A.
 
- 
                        Virtual patient derived xenografts for tumor treatment- Leader
- Jaume Mora Graupera
- Announcement
- Health Research 2020
- Code
- HR20-00411
- Starting date
- 2020
- End date
- 2023
- Funded by
- Fundació Bancària " La Caixa"
 
- 
                        Unveiling the Ewing sarcoma cell of origin: a multistep transformation process that involves prenatal genetic and postnatal epigenetic mechanisms- Leader
- Jaume Mora Graupera
- Announcement
- Projectes de recerca en càncer
- Code
- 201928-30
- Starting date
- 2020
- End date
- 2023
- Funded by
- Fundació La Marató de TV3
 
- 
                        Mapping the pathogenesis of vascular malformations- Leader
- Eulalia Baselga Torres
- Announcement
- Health Research 2018
- Code
- HR18-00120
- Starting date
- 2019
- End date
- 2023
- Funded by
- Fundació Bancària " La Caixa"
 
- 
                        Ipatasertib in Rhabdomyosarcoma- Leader
- Jaume Mora Graupera
- Code
- PCP00248
- Starting date
- 2019
- End date
- 2021
- Funded by
- Roche Diagnostics International Ltd
 
- 
                        SHARE4RARE: Social media platform dedicated to rare diseases, using collective intelligence for the generation of awareness and advanced knowledge on this large group of diseases- Leader
- Begoña Nafria Escalera
- Announcement
- H2020-ICT-11-2017
- Code
- 780262
- Starting date
- 2018
- End date
- 2021
- Funded by
- European Commission
 
- 
                        Modelo de terapia de precisión: tratamientos personalizados de rescate para cada paciente (en base a las anomalías genéticas del tumor y el test de fármacos en modelo animal)- Leader
- Jaume Mora Graupera
- Announcement
- Proyectos en cáncer infantil
- Code
- PCP00232
- Starting date
- 2018
- End date
- 2019
- Funded by
- Fundación Inocente Inocente
 
- 
                        SGR 2017_Grup de Recerca en tumors del desenvolupament- Leader
- Jaume Mora Graupera
- Announcement
- SGR 2017-2019
- Code
- 2017 SGR 01672
- Starting date
- 2017
- End date
- 2021
- Funded by
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
 
- 
                        Caracterización y relevancia del entorno epigenético en el desarrollo del sarcoma de Ewing- Leader
- Jaume Mora Graupera
- Announcement
- Proyectos de investigación en salud
- Code
- PI16/00245
- Starting date
- 2017
- End date
- 2020
- Funded by
- Instituto de Salud Carlos III (ISCIII)
 
- 
                        Fundación Leo Messi_Convenio Rabdomiosarcoma- Leader
- Jaume Mora Graupera
- Code
- PFNR0068
- Starting date
- 2016
- End date
- 2019
- Funded by
- Fundación Privada Leo Messi
 
